Interventional device developer Boston Scientific of Natick, MA, has introduced its self-expanding nitinol biliary stent system, Sentinol, to the U.S. market.
The stent has been cleared by the Food and Drug Administration for the treatment of malignant biliary obstruction, Boston Scientific said.
By AuntMinnie.com staff writersApril 8, 2004
Related Reading
FDA approves Boston Scientific fibroids treatment, March 30, 2004
Boston Scientific, EndoTex complete enrollment, March 25, 2004
Boston Scientific gets FDA approval for Taxus, March 5, 2004
Boston Scientific to build intercontinental distribution center, March 4, 2004
Boston Scientific, Guidant settle litigation, February 23, 2004
Copyright © 2004 AuntMinnie.com